Bounded weak solutions for Keller-Segel equations with generalized diffusion and logistic source via an unbalanced optimal transport splitting scheme
Nonlinear Analysis · 2026-11 · 272 · 114205
DOI: 10.1016/j.na.2026.114205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nonlinear Analysis, 2026-11. Verfasst von Kyungkeun Kang und 2 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Ministry of Science and ICT, South Korea, National Research Foundation of Korea.
Abstract (Originalsprache)
We consider a parabolic-elliptic type of Keller-Segel equations with generalized diffusion and logistic source under homogeneous Neumann-Neumann boundary conditions. We construct bounded weak solutions globally in time in an unbalanced optimal transport framework, provided that the magnitude of the chemotactic sensitivity can be restricted depending on parameters. In the case of subquadratic degradation of the logistic source, we quantify the chemotactic sensitivity, in particular, in terms of the power of degradation and the pointwise bound of the initial density.
Förderung
- Ministry of Science and ICT, South Korea
- National Research Foundation of Korea
Zitieren
APA
Kang, K., Kim, H. K., & Seo, G. (2026). Bounded weak solutions for Keller-Segel equations with generalized diffusion and logistic source via an unbalanced optimal transport splitting scheme. Nonlinear Analysis, 272, 114205. https://doi.org/10.1016/j.na.2026.114205
Vancouver
Kang K, Kim HK, Seo G. Bounded weak solutions for Keller-Segel equations with generalized diffusion and logistic source via an unbalanced optimal transport splitting scheme. Nonlinear Analysis. 2026;272:114205. doi:10.1016/j.na.2026.114205
BibTeX
@article{Kang2026,
author = {Kang, Kyungkeun and Kim, Hwa Kil and Seo, Geuntaek},
title = {Bounded weak solutions for Keller-Segel equations with generalized diffusion and logistic source via an unbalanced optimal transport splitting scheme},
journal = {Nonlinear Analysis},
year = {2026},
volume = {272},
pages = {114205},
doi = {10.1016/j.na.2026.114205}
}
EUVIMED